# US 2012/0252885 A1 · Dronabinol treatment for migraines

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252885 A1
- Document ID: US20120252885A1
- Status: Published application
- Kind: A1
- Application number: 13/483,211
- Filed: 2012-05-30
- Published: 2012-10-04
- Earliest claimed: 2005-06-20
- Inventors: Lou Barbato
- Web page: https://patentgrep.com/patent/US20120252885A1

## CPC

- A61K 9/008: {comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]}
- A61K 31/35: having six-membered rings with one oxygen as the only ring hetero atom
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61P 25/06: Antimigraine agents
- A61K 9/0075: {for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles}
- A61K 9/48: Preparations in capsules, e.g. of gelatin, of chocolate {(A61K9/0004 takes precedence; bite capsules A61K9/0056)}
- A61K 9/7023: {Transdermal patches and similar drug-containing composite devices, e.g. cataplasms (galenical aspects of iontophoretic devices A61K9/0009; microneedle arrays A61K9/0021; buccal patches A61K9/006)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

In various embodiments, the present invention provides pharmaceutical compositions comprising delta-9-tetrahydrocannabinol and methods of administering such compositions to treat migraines.

## Claims

### Claim 1

A method of treating migraine headaches comprising administering to a subject in need thereof an effective amount of dronabinol through a metered dose inhaler.

### Claim 2 (depends on 1)

The method of claim 1, wherein the metered dose inhaler comprises about 0.5% delta-9-THC, about 10% dehydrated alcohol, and about 89.5.0% 1,1,1,2 tetrafluoroethane.

### Claim 3 (depends on 1)

The method of claim 1, wherein the metered dose inhaler comprises about 2.0% delta-9-THC, about 10% dehydrated alcohol, and about 88.0% 1,1,1,2 tetrafluoroethane.

### Claim 4 (depends on 1)

The method of claim 1, wherein the metered dose inhaler is obtained from a physician.

### Claim 5

A method of treating migraine headaches comprising administering to a subject in need thereof an effective amount of dronabinol through an orally deliverable dosage unit.

### Claim 6 (depends on 5)

The method of claim 5, wherein the orally deliverable dosage unit is a capsule.

### Claim 7

A method of treating migraine headaches comprising administering to a subject in need thereof an effective amount of dronabinol through a transdermal delivery system

### Claim 8 (depends on 7)

The method of claim 7, wherein the transdermal delivery system is a patch.

### Claim 9

A method of treating acute migraine headaches in a subject in need thereof comprising treating the periaqueductal region of the brain by administering an effective amount of dronabinol.

### Claim 10

A method of treating acute migraine headaches in a subject in need thereof comprising reducing platelet aggregation in the subject by administering an effective amount of dronabinol.
